Search

Search Constraints

You searched for: Author/Creator Briers, Erik

Search Results

1. Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study. (January 2023)

2. Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity. (June 2021)

4. Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement. Issue 3 (December 2016)

5. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study). (April 2022)

6. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer. (September 2019)

7. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study. (November 2022)

8. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer. (March 2022)